PharmaTher Holdings Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHRRF research report →
About the company
PharmaTher Holdings Ltd. is a biotechnology firm in the clinical stage, specializing in psychedelic treatments. Its primary objective is to investigate, develop, and bring to market innovative applications, drug forms, and administration techniques for psychedelics, addressing conditions such as mental health issues, neurological diseases, and chronic pain.
- CEO
- Fabio Chianelli
- IPO
- 2021
- Employees
- 5
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $3.37M
- P/E
- -4.13
- P/S
- 0.00
- P/B
- 8.53
- EV/EBITDA
- -2.65
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -155.46%
- ROIC
- -241.01%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,526,106 · 51.01%
- EPS
- $-0.02 · 51.27%
- Op Income
- $-1,523,637
- FCF YoY
- 65.64%
- 52W High
- $0.55
- 52W Low
- $0.04
- 50D MA
- $0.05
- 200D MA
- $0.08
- Beta
- 2.36
- Avg Volume
- 200.62K
Get TickerSpark's AI analysis on PHRRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PHRRF coverage
Recent articles, reports, and earnings notes.
No research on PHRRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHRRF report →Similar companies
Peers in the same neighborhood.